DTC Restrictions Ahead: Risk Management Plans, “Drug Watch” Are Vehicles
Executive Summary
FDA will manifest its tougher stance on DTC advertising in requirements for more extensive risk management plans, Hogan & Hartson Partner Robert Brady predicted at a Regulatory Affairs Professionals Society conference in Chicago